Skip to main content
See every side of every news story
Published • loading... • Updated

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Average Target Price of $904.41

Summary by MarketBeat
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Get Free Report) have been given a consensus rating of "Moderate Buy" by the thirty-one ratings firms that are currently covering the firm, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation, twenty-one

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal